Results The study population was sex-balanced with a small predominance of women, who
were older than men. We observed reduction of age between the first and third time interval (…

Air pollution can adversely affect the immune response and increase the severity of the viral
disease. The present study aimed to explore the relationship between symptomatology, …

Long-term analyses of demographical and clinical characteristics of COVID-19 patients can
provide a better overview of the clinical course of the disease. They can also help …

Because the optimal treatment for COVID-19 is still unknown, it is important to explore every
potential way of improving the chances of survival for COVID-19 patients. The aim of the …

Background: Patients with kidney failure are at an increased risk of progression to a severe
form of coronavirus disease 2019 (COVID-19) with high mortality. The current analysis was …

Background Remdesivir (RDV) is the only antiviral drug registered currently for treatment of
COVID-19 after a few clinical trials with controversial results. The purpose of this study was to …

Simple Summary Patients with active malignancies have an increased risk for severe SARS-CoV-2
infection and high mortality from COVID-19. Additionally, due to the underlying …

BACKGROUND Nearly 290000 patients with chronic hepatitis C die annually from the most
severe complications of the disease. One of them is liver cirrhosis, which occurs in about 20…

Purpose Since 2017 treatment-naïve patients infected with genotype 1b of hepatitis C virus
and minimal or moderate fibrosis can be treated with Ombitasvir/Paritaprevir/ritonavir + …

There is still limited data available from real-world experience studies on the pangenotypic
regimens in patients with genotype (GT) 3 hepatitis C virus (HCV) infection and liver cirrhosis. …